Hemab Therapeutics
Denmark - CopenhagenBiotechnology
Focus: Hemab Therapeutics is a Copenhagen-based biotechnology company focused on bleeding disorder treatments, operating at Series C+ stage with 5,000+ employees. The company specializes in hematology with a portfolio spanning rare bleeding conditions including von Willebrand disease, Glanzmann thrombasthenia, and congenital factor deficiencies.
Profile data last refreshed 22h ago · AI intelligence enriched 1w ago
Funding Stage
SERIES C +
Employees
5000+
Open Jobs
0
About Hemab Therapeutics
AI assessmentNot HiringNo open roles listed right now. Follow Hemab Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from Hemab Therapeutics's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
3/9 — Basic
Company HealthSolid
Pipeline
Early-stage
9 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Comparison of blood samples between the two groups
Leiomyoma, UterineClinical Trials (1)
NCT05607602Are Uterine Fibroids Pro-thrombotic?
N/AHelp build intelligence for Hemab Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.